Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency.
J Clin Invest. 2024 Feb 20;134(8):e175199. doi: 10.1172/JCI175199.
J Clin Invest. 2024.
PMID: 38376944
Free PMC article.
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.
Van Oekelen O, Nath K, Mouhieddine TH, Farzana T, Aleman A, Melnekoff DT, Ghodke-Puranik Y, Shah GL, Lesokhin A, Giralt S, Thibaud S, Rossi A, Rodriguez C, Sanchez L, Richter J, Richard S, Cho HJ, Chari A, Usmani SZ, Jagannath S, Shah UA, Mailankody S, Parekh S.
Van Oekelen O, et al. Among authors: melnekoff dt.
Blood. 2023 Feb 16;141(7):756-765. doi: 10.1182/blood.2022017848.
Blood. 2023.
PMID: 36327160
Free PMC article.
Item in Clipboard
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma.
Mouhieddine TH, Van Oekelen O, Melnekoff DT, Li J, Ghodke-Puranik Y, Lancman G, Thibaud S, Pan D, Rajeeve S, Agte S, Aleman A, Sanchez L, Richard S, Rossi A, Richter J, Cho HJ, Rodriguez C, Lagana A, Moshier E, Chari A, Jagannath S, Parekh S.
Mouhieddine TH, et al. Among authors: melnekoff dt.
Blood Adv. 2023 Mar 28;7(6):1056-1064. doi: 10.1182/bloodadvances.2022007923.
Blood Adv. 2023.
PMID: 36018226
Free PMC article.
Clinical Trial.
Item in Clipboard
A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma.
Restrepo P, Bhalla S, Ghodke-Puranik Y, Aleman A, Leshchenko V, Melnekoff DT, Agte S, Jiang J, Madduri D, Richter J, Richard S, Chari A, Cho HJ, Jagannath S, Walker CJ, Landesman Y, Laganà A, Parekh S.
Restrepo P, et al. Among authors: melnekoff dt.
JCO Precis Oncol. 2022 Jun;6:e2200147. doi: 10.1200/PO.22.00147.
JCO Precis Oncol. 2022.
PMID: 35704796
Free PMC article.
Item in Clipboard
Single-Cell Sequencing Technologies in Precision Oncology.
Melnekoff DT, Laganà A.
Melnekoff DT, et al.
Adv Exp Med Biol. 2022;1361:269-282. doi: 10.1007/978-3-030-91836-1_15.
Adv Exp Med Biol. 2022.
PMID: 35230694
Review.
Item in Clipboard
Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications.
Bhalla S, Melnekoff DT, Aleman A, Leshchenko V, Restrepo P, Keats J, Onel K, Sawyer JR, Madduri D, Richter J, Richard S, Chari A, Cho HJ, Dudley JT, Jagannath S, Laganà A, Parekh S.
Bhalla S, et al. Among authors: melnekoff dt.
Sci Adv. 2021 Nov 19;7(47):eabg9551. doi: 10.1126/sciadv.abg9551. Epub 2021 Nov 17.
Sci Adv. 2021.
PMID: 34788103
Free PMC article.
Item in Clipboard
A phase II study of pomalidomide, daily oral cyclophosphamide, and dexamethasone in relapsed/refractory multiple myeloma.
Van Oekelen O, Parekh S, Cho HJ, Vishnuvardhan N, Madduri D, Richter J, Ip C, Lau K, Florendo E, Mancia IS, Thomas J, Verina D, Chan E, Zarychta K, La L, Strumolo G, Melnekoff DT, Leshchenko VV, Kim-Schulze S, Couto S, Wang M, Pierceall WE, Thakurta A, Laganà A, Jagannath S, Chari A.
Van Oekelen O, et al. Among authors: melnekoff dt.
Leuk Lymphoma. 2020 Sep;61(9):2208-2215. doi: 10.1080/10428194.2020.1805111. Epub 2020 Aug 19.
Leuk Lymphoma. 2020.
PMID: 32812822
Clinical Trial.
Item in Clipboard
Cite
Cite